Genoptix provides the vital insights cancer care teams need to achieve the best possible outcome for each and every patient. Our testing services have the unique capability to combine data from both pathology and next-generation genomics into one comprehensive report that enables confident, data-driven decisions and optimizes precision medicine. Having served over 1.7 million patients, Genoptix sets a higher standard of quality, from science to service. Because what matters most is delivering the right answer, right now.
For more information visit www.genoptix.com